Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 21.15
0.00 (0.00%)
May 16, 2025, 10:07 AM CST
Bioray Biotech Revenue
In the year 2024, Bioray Biotech had annual revenue of 201.71M TWD with 5.15% growth. Bioray Biotech had revenue of 85.80M in the half year ending June 30, 2024, a decrease of -3.45%.
Revenue
201.71M
Revenue Growth
+5.15%
P/S Ratio
3.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
630.97M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.33M |
| Pegavision | 6.69B |
| Center Laboratories | 1.63B |